期刊文献+

子宫平滑肌肉瘤16例临床分析 被引量:6

16 Cases Reports of Uterine Leiomyosarcoma
下载PDF
导出
摘要 目的:探讨子宫平滑肌肉瘤(LMS)的临床病理特征,以期对该病的诊治提供帮助。方法:回顾性分析16例LMS患者的临床表现、病理特点及诊治情况。结果:LMS占子宫肉瘤的31.4%(16/51),平均发病年龄为52岁。16例中阴道不规则流血4例,腹部胀痛5例,盆腔包块8例。包块平均直径约7.5cm,3例包块内部血流阻力指数平均0.35。病理分期Ⅰ期12例。显微镜下见肿瘤细胞有程度不等的异型性,7例可见凝固性坏死。6例检测平滑肌肌动蛋白(SMA)5例为阳性;7例检测细胞增殖标记(Ki-67)的表达,均大于5%。术前仅1例因活检脱出的宫颈内容物而诊断为平滑肌肉瘤,其余经术后病理检查确诊。所有患者均手术治疗,12例辅以化疗。13例随访病例中3例死亡,1例复发。结论:子宫平滑肌肉瘤临床表现多样,以盆腔包块为主。肿瘤细胞有不同程度异型性,可见凝固性坏死。术前诊断困难,术后病理检查为确诊手段,免疫组化检测有助于诊断。病理分期低的患者经积极手术并辅以化疗,预后较好。 Objective:To investigate the clinical,histopathological features of uterine leiomyosarcoma for improvement of its diagnosis and treatment. Methods:Clinical and histopathological features,treatments of 16 cases diagnosed as uterine leiomyosarcoma were retrospectively analyzed. Results:Uterine leiomyosarcoma accounted for 31.4% of all uterine sarcoma in our hospital. The mean onset age was 52 years. Of the 16 cases,4 patients had irregular vaginal bleeding,5 patients had abdominal pain,8 patients were found pelvic mass. The mean tumor size was 7.5 cm,while the mean blood flow resistance index of 3 patients was 0.35. There were 12 cases of stage I. Varing degrees of atypia was seen in all cases,and coagulation necrosis was seen in 7 cases under microscope. As for immunohistochemical test, smooth muscle actin were tested in 6 cases,of which 5 cases was positive,while Ki-67 was positive in all 7 cases tested. Only one case was diagnosed as LMS because biopsy of tissue from uterine was made. 3 cases were misdiagnosed as hysteromyom,1 case was misdiagnosed as oophoroma. All cases were diagnosed definitly by pathologic test. All of them undertook operative treatment,of which 12 had chemo-treatment. 13 cases were followed-up,of which 3patients had died and 1 patient had recurrence of the disease. Conclusions:Clinical features of LMS are varied,the main symptom was pelvic mass. Varing degrees of atypia and coagulation necrosis are seen in tumor cells under microscope. It is difficult to make a definite diagnosis before operation. Pathologic examination is the definite diagnosis method, and immunohistochemical test is helpful for its diagnosis. The prognosis of uterine leiomyosarcoma can be improved if the patients can be diagnosed in early stage and be treated by operation and chemicotherapy timely.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2013年第2期144-146,共3页 Journal of Practical Obstetrics and Gynecology
关键词 子宫平滑肌肉瘤 子宫肉瘤 病理分期 预后 Uterine leiomyosarcoma Uterine sarcoma Pathological stage Prognosis
  • 相关文献

参考文献6

  • 1Szabo I, Szantho A, Csabay I, et al. Color Doppler uhramnography in the differentiation of uterine sarcomas from uterine leiomyomas [ J 1. Eur J Gynecol 0ncol,2002,23 ( 1 ) :29 - 34.
  • 2孙旸,付晓宇,宋磊.子宫肉瘤分子标记物临床应用的研究进展[J].现代妇产科进展,2007,16(2):140-142. 被引量:3
  • 3Robert L, Giuntoli RL, Daniel S, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus : prognostic indicators, sur- gical management, and adjuvant therapy [ J ]. Gynecologic Oncology, 2003,78(4) :460 -469.
  • 4蒋春萍,Selvan Pather,Chris Dalrymple,Ehab Al-Rayyan,Marcelo Nascimento,Philip Beale,Michael Jackson,Chris Milross,Jonathan Carter.子宫平滑肌肉瘤的治疗预后-来自悉尼妇科肿瘤中心的报告[J].国际医药卫生导报,2009,15(17):24-28. 被引量:2
  • 5Kapp DS, Shin JY, Chan JL. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas:emphasis on impact of lymph- adenectomy and oophorectomy [ J ]. Cancer, 2008, 112 ( 4 ) : 820 - 830.
  • 6Giuntoli RL, Matzinger DS, Di Marco CS, et al. Retrospcetive review of 208 patients with leiomyosarcoma of the uterus : prognosis indicate- ors, surgical management, and ajuvant therapy [ J 1. Gyneeol Oncol, 2003,89(3) :460-469.

二级参考文献32

  • 1Sheetal A,Martee LH,et al.Rare uterine cancer[J].Lancet Oncol,2005,6:961-971.
  • 2Klaus B,Barbara BA,et al.Evaluating prognostic parameters in women with uterine leiomyosarcoma[J].The Journal of Reproductive Medicine,2003,48:95-99.
  • 3Robert LGII,Robert EB.Uterine leiomyosarcoma:present management[J].Current Opinion in Oncology,2004,16:324-27.
  • 4Gregory B,Gard F,et al.Management of uterine leimyosarcoma in Australia[J].Aust NZ J Obstet Gynaecol,1999,39(1):39-98.
  • 5Melone GA,D'Elia A,Brogna C,Salvati M.Tumori[J].Uterine leiomyosarcoma metastatic to the brain:case report·Tumori,2008,94(6):856-860.
  • 6Omoniyi-Esan GO,Badmos KB,Adeyemi AB,et al.Leiomyosarcoma of the uterus:a clinicopathological report of two cases and review of literature[J].Afr J Med Med Sci,2008,37(3):285-288.
  • 7Giuntoli RL,Metzinger DS,DiMarco CS,et al.Retrospective review of 208 patients with leiomyosarcoma of the uterus:Prognostic indicators,surgical management,and adjuvant therapy[J].Gynecol Oncol,2003,89(3):460-469.
  • 8Gadducci A,Landoni F,Sartori E,et al.Uterine leiomyosarcoma:analysis of treatment failures and survival[J].Gynecol Oncol,1996,62:25-32.
  • 9Leitao MM,Sonoday,Brennan MF,et al.Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus[J].Gynecol Oncol,2003,9(1):209-212.
  • 10Goff BA,Rice LW,Fleischhacker D,et al.Uterine leiomyosarcoma and endometrial stromal sarcoma:lymph node metastases and site of reeurrence[J].Gynecol Oncol,1993,50:105-109.

共引文献3

同被引文献39

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部